San Antonio-based Fe3 Medical disclosed Wednesday it has raised $11 million from investors to fund clinical trials of a transdermal patch it has developed for patients suffering from iron-deficiency anemia.
Newsroom
San Antonio-based Fe3 Medical disclosed Wednesday it has raised $11 million from investors to fund clinical trials of a transdermal patch it has developed for patients suffering from iron-deficiency anemia.